{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T21:11:54Z","timestamp":1765141914036,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41366-019-0321-4","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T15:05:38Z","timestamp":1547823938000},"page":"159-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Adenovirus 36 seropositivity is related to obesity risk, glycemic control, and leptin levels in Chilean subjects"],"prefix":"10.1038","volume":"44","author":[{"given":"Jorge","family":"Sapunar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ines","family":"Barra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Manr\u00edquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Pavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3428-8332","authenticated-orcid":false,"given":"Alvaro","family":"Cerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-2796.2008.01922.x","volume":"263","author":"WP James","year":"2008","unstructured":"James WP. The epidemiology of obesity: the size of the problem. J Intern Med. 2008;263:336\u201352.","journal-title":"J Intern Med"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1043-4526(06)52002-9","volume":"52","author":"M Pasarica","year":"2007","unstructured":"Pasarica M, Dhurandhar NV. Infectobesity: obesity of infectious origin. Adv Food Nutr Res. 2007;52:61\u2013102.","journal-title":"Adv Food Nutr Res"},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jcv.2012.06.009","volume":"55","author":"S Esposito","year":"2012","unstructured":"Esposito S, Preti V, Consolo S, Nazzari E, Principi N. Adenovirus 36 infection and obesity. J Clin Virol. 2012;55:95\u2013100.","journal-title":"J Clin Virol"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1093\/jn\/131.10.3155","volume":"132","author":"NV Dhurandhar","year":"2002","unstructured":"Dhurandhar NV, Whigham LD, Abbott DH, Schultz-Darken NJ, Israel BA, Bradley SM, et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr. 2002;132:3155\u201360.","journal-title":"J Nutr"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/17477160903111789","volume":"5","author":"RL Atkinson","year":"2010","unstructured":"Atkinson RL, Lee I, Shin HJ, He J. Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes. 2010;5:157\u201360.","journal-title":"Int J Pediatr Obes"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ijo.2009.207","volume":"34","author":"HN Na","year":"2010","unstructured":"Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes. 2010;34:89\u201393.","journal-title":"Int J Obes"},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.micpath.2017.04.034","volume":"108","author":"B Kocazeybek","year":"2017","unstructured":"Kocazeybek B, Dinc HO, Ergin S, Saribas S, Ozcabi BT, Cizmecigil U, et al. Evaluation of adenovirus-36 (Ad-36) antibody seropositivity and adipokine levels in obese children. Microb Pathog. 2017;108:27\u201331.","journal-title":"Microb Pathog"},{"key":"321_CR8","doi-asserted-by":"publisher","unstructured":"Tosh AK, Wasserman MG, McLeay II MT, Tepe SK. Human adenovirus-36 seropositivity and obesity among Midwestern US adolescents. Int J Adolesc Med Health. 2017. \nhttps:\/\/doi.org\/10.1515\/ijamh-2017-0126\n\n.","DOI":"10.1515\/ijamh-2017-0126"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ijo.0802830","volume":"29","author":"RL Atkinson","year":"2005","unstructured":"Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes. 2005;29:281\u20136.","journal-title":"Int J Obes"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1038\/ijo.2009.196","volume":"33","author":"GM Trovato","year":"2009","unstructured":"Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C, et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes. 2009;33:1402\u20139.","journal-title":"Int J Obes"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1017\/S0950268815000679","volume":"143","author":"M Karamese","year":"2015","unstructured":"Karamese M, Altoparlak U, Turgut A, Aydogdu S, Karamese SA. The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in Turkish children and adults. Epidemiol Infect. 2015;143:3550\u20136.","journal-title":"Epidemiol Infect"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/oby.2009.452","volume":"19","author":"VJ Goossens","year":"2011","unstructured":"Goossens VJ, deJager SA, Grauls GE, Gielen M, Vlietinck RF, Derom CA, et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity. 2011;19:220\u20131.","journal-title":"Obesity"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/ijo.2009.224","volume":"34","author":"MP Broderick","year":"2010","unstructured":"Broderick MP, Hansen CJ, Irvine M, Metzgar D, Campbell K, Baker C, et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes. 2010;34:302\u20138.","journal-title":"Int J Obes"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ijo.2011.102","volume":"36","author":"HN Na","year":"2012","unstructured":"Na HN, Kim J, Lee HS, Shim KW, Kimm H, Jee SH, et al. Association of human adenovirus-36 in overweight Korean adults. Int J Obes. 2012;36:281\u20135.","journal-title":"Int J Obes"},{"key":"321_CR15","doi-asserted-by":"crossref","unstructured":"Zhou Y, Pan Q, Wang X, Zhang L, Xiao F, Guo L. The relationship between human adenovirus 36 and obesity in Chinese Han population. Biosci Rep. 2018;38:BSR20180553.","DOI":"10.1042\/BSR20180553"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"e2357","DOI":"10.1097\/MD.0000000000002357","volume":"94","author":"MY Xu","year":"2015","unstructured":"Xu MY, Cao B, Wang DF, Guo JH, Chen KL, Shi M, et al. Human adenovirus 36 infection increased the risk of obesity: a meta-analysis update. Medicine. 2015;94:e2357.","journal-title":"Medicine"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u2013421.","journal-title":"Circulation"},{"key":"321_CR18","unstructured":"Chang X, Jiao Y, Lu J-F, Nurbiya N, Guan Y-Q. The regulation of adenovirus type 36 infection and progranulin expression in Uygur obese patients. J Xian Jiaotong Univ (Med Sci). 2015;36:219\u201324."},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"e41652","DOI":"10.1371\/journal.pone.0041652","volume":"7","author":"M Almgren","year":"2012","unstructured":"Almgren M, Atkinson R, He J, Hilding A, Hagman E, Wolk A, et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One. 2012;7:e41652.","journal-title":"PLoS One"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"e42031","DOI":"10.1371\/journal.pone.0042031","volume":"7","author":"T Yamada","year":"2012","unstructured":"Yamada T, Hara K, Kadowaki T. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. PLoS One. 2012;7:e42031.","journal-title":"PLoS One"},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.ijo.0801319","volume":"24","author":"NV Dhurandhar","year":"2000","unstructured":"Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL. Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord. 2000;24:989\u201396.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/ijo.2015.163","volume":"39","author":"E Ponterio","year":"2015","unstructured":"Ponterio E, Cangemi R, Mariani S, Casella G, De Cesare A, Trovato FM, et al. Adenovirus 36 DNA in human adipose tissue. Int J Obes. 2015;39:1761\u20134.","journal-title":"Int J Obes"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1634\/stemcells.2007-0868","volume":"26","author":"M Pasarica","year":"2008","unstructured":"Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, Permana P, et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells. 2008;26:969\u201378.","journal-title":"Stem Cells"},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/oby.2004.93","volume":"12","author":"SD Vangipuram","year":"2004","unstructured":"Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res. 2004;12:770\u20137.","journal-title":"Obes Res"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ijo.0803366","volume":"31","author":"SD Vangipuram","year":"2007","unstructured":"Vangipuram SD, Yu M, Tian J, Stanhope KL, Pasarica M, Havel PJ, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes. 2007;31:87\u201396.","journal-title":"Int J Obes"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.ijo.0803748","volume":"32","author":"PM Rogers","year":"2008","unstructured":"Rogers PM, Fusinski KA, Rathod MA, Loiler SA, Pasarica M, Shaw MK, et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes. 2008;32:397\u2013406.","journal-title":"Int J Obes"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10620-011-1903-8","volume":"57","author":"GM Trovato","year":"2012","unstructured":"Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A, et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci. 2012;57:535\u201344.","journal-title":"Dig Dis Sci"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/j.1478-3231.2009.02127.x","volume":"30","author":"GM Trovato","year":"2010","unstructured":"Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C, et al. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int. 2010;30:184\u201390.","journal-title":"Liver Int"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"14706","DOI":"10.3748\/wjg.v20.i40.14706","volume":"20","author":"FM Trovato","year":"2014","unstructured":"Trovato FM, Catalano D, Garozzo A, Martines GF, Pirri C, Trovato GM. ADV36 adipogenic adenovirus in human liver disease. World J Gastroenterol. 2014;20:14706\u201316.","journal-title":"World J Gastroenterol"},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.2337\/db07-1313","volume":"57","author":"ZQ Wang","year":"2008","unstructured":"Wang ZQ, Cefalu WT, Zhang XH, Yu Y, Qin J, Son L, et al. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes. 2008;57:1805\u201313.","journal-title":"Diabetes"},{"key":"321_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2337\/dc12-1089","volume":"36","author":"WY Lin","year":"2013","unstructured":"Lin WY, Dubuisson O, Rubicz R, Liu N, Allison DB, Curran JE, et al. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection. Diabetes Care. 2013;36:701\u20137.","journal-title":"Diabetes Care"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jdiacomp.2012.09.006","volume":"27","author":"NV Dhurandhar","year":"2013","unstructured":"Dhurandhar NV. Insulin sparing action of adenovirus 36 and its E4orf1 protein. J Diabetes Complications. 2013;27:191\u20139.","journal-title":"J Diabetes Complications"},{"key":"321_CR33","doi-asserted-by":"publisher","first-page":"e23394","DOI":"10.1371\/journal.pone.0023394","volume":"6","author":"EJ Dhurandhar","year":"2011","unstructured":"Dhurandhar EJ, Dubuisson O, Mashtalir N, Krishnapuram R, Hegde V, Dhurandhar NV. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One. 2011;6:e23394.","journal-title":"PLoS One"},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2337\/db16-0876","volume":"66","author":"TB McMurphy","year":"2017","unstructured":"McMurphy TB, Huang W, Xiao R, Liu X, Dhurandhar NV, Cao L. Hepatic expression of adenovirus 36 E4ORF1 improves glycemic control and promotes glucose metabolism through AKT activation. Diabetes. 2017;66:358\u201371.","journal-title":"Diabetes"},{"key":"321_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.micpath.2015.02.008","volume":"80","author":"S Ergin","year":"2015","unstructured":"Ergin S, Altan E, Pilanci O, Sirekbasan S, Cortuk O, Cizmecigil U, et al. The role of adenovirus 36 as a risk factor in obesity: the first clinical study made in the fatty tissues of adults in Turkey. Microb Pathog. 2015;80:57\u201362.","journal-title":"Microb Pathog"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41366-019-0321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41366-019-0321-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41366-019-0321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:33Z","timestamp":1684617333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-019-0321-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1038\/s41366-019-0321-4","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"type":"print","value":"0307-0565"},{"type":"electronic","value":"1476-5497"}],"subject":[],"published":{"date-parts":[[2019,1,18]]},"assertion":[{"value":"9 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}